Posted in Web EU bulks up its arsenal against Omicron with approval of … January 18, 2022 Nuvaxovid would be the first protein-based vaccine authorised to combat the coronavirus in the EU, but its efficacy against Delta and Omicron is unproven. https://fortune.com/2021/12/20/eu-bulks-up-its-arsenal-against-omicron-with-approval-of-novavax-vaccine-investors-dump-shares/